Fundz

Aspargo Laboratories

ENGLEWOOD CLIFFS, New Jersey, United States · Biotechnology, Healthcare

Aspargo Labs, Inc. is a specialty pharmaceutical and MedTech company focused on converting the world’s most meaningful medications into liquid oral suspensions delivered via a proprietary, digitally connected device. Aspargo Labs’ suspension technology offers several key advantages, including improved absorption, ease of administration, flexible dosing, and improved patient adherence. Aspargo is l

Key facts

Headquarters
ENGLEWOOD CLIFFS, New Jersey, United States
Employees
17
Industries
Biotechnology, Healthcare
Status
Private
Website
aspargolabs.com
LinkedIn
Company page

Recent activity at Aspargo Laboratories

Aspargo Laboratories funding history

DateRoundAmount
Dec 2022Seed$290K
Mar 2022Seed$1.5M
Mar 2020Pre-Seed$235K

Leadership

  • Michael Demurjian, Executive Officer, Director, Promoter
  • Michael Rice, Director
  • Fred Biehl, Director
  • Sam Backenroth, Chief Financial Officer
  • Mario Guralnik, Chief Regulatory Officer

Verified email and direct lines for Aspargo Laboratories’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.

Aspargo Laboratories in the news

Companies similar to Aspargo Laboratories

About Aspargo Laboratories: questions and answers

What does Aspargo Laboratories do?

Aspargo Labs, Inc. is a specialty pharmaceutical and MedTech company focused on converting the world’s most meaningful medications into liquid oral suspensions delivered via a proprietary, digitally connected device. Aspargo Labs’ suspension technology offers several key advantages, including improved absorption, ease of administration, flexible dosing, and improved patient adherence. Aspargo is l

Where is Aspargo Laboratories headquartered?

Aspargo Laboratories is headquartered in ENGLEWOOD CLIFFS, New Jersey, United States.

How many employees does Aspargo Laboratories have?

Aspargo Laboratories has about 17 employees.

Has Aspargo Laboratories raised funding?

Yes. Fundz has recorded 3 funding events for Aspargo Laboratories. The most recent, Seed of $290K, was in Dec 2022.

What is the latest news on Aspargo Laboratories?

On Feb 18, 2026, Aspargo Labs Appoints Sam Backenroth as Chief Financial Officer

Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy

Fundz watches Aspargo Laboratories across 18 signal types, from funding and M&A to exec moves and hiring.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.